Liposomes containing NY-ESO-1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccines

Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation

(2011) P. J. Tacken et al.   BLOOD

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity

(2011) P. J. Tacken et al.   BLOOD

Production of antibodies with peptide-CpG-DNA-liposome complex without carriers

(2011) Dongbum Kim et al.   BMC IMMUNOLOGY

Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid–immunoglobulin complexes in humans

(2011) Yun Lin et al.   JOURNAL OF CLINICAL INVESTIGATION

Enhancing immune responses to tumor-associated antigens

(2010) Jack P. Higgins et al.   CANCER BIOLOGY & THERAPY

Designing Vaccines Based on Biology of Human Dendritic Cell Subsets

(2010) Karolina Palucka et al.   IMMUNITY

Targeting Nanosystems to Human DCs via Fc Receptor as an Effective Strategy to Deliver Antigen for Immunotherapy

(2010) Luis J. Cruz et al.   MOLECULAR PHARMACEUTICS

A Schistosoma japonicumchimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens

(2009) Xindong Xu et al.   BMC INFECTIOUS DISEASES

Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma

(2009) Jian-min Yang et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Dendritic cell-based therapeutic cancer vaccines: what we have and what we need

(2009) Pawel Kalinski et al.   Future Oncology

Anti-idiotypic Immunotherapy in Follicular Lymphoma Patients

(2009) Rosa Yáñez et al.   JOURNAL OF IMMUNOTHERAPY

Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers

(2008) C. Lundegaard et al.   BIOINFORMATICS